Search filters

Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 20 April 2016
Author/s

author: Johnny Duerinck  Bart Neyns 

Publication date April 20, 2016
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item